Mycophenolate mofetil: An open-label study in 42 MS patients

被引：0
|
作者：
Vukusic, S. [1 ]
Ducray, F. [1 ]
Gignoux, L. [1 ]
Durand-Dubief, F. [1 ]
Achiti, I. [1 ]
Blanc, S. [1 ]
Confavreux, C. [1 ]
机构：
[1] Hop Neurol & Neurochirurg P Wertheimer, Dept Neurol A, Lyon, France
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [31] A Phase III, open-label study to evaluate the effect of ocrelizumab on immune responses in patients with relapsing MS
    Millar, L.
    Li, C.
    Bennett, H.
    Garren, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 407 - 407
  • [32] Mycophenolate Mofetil for Induction and Maintenance of Remission in Microscopic Polyangiitis with Mild to Moderate Renal Involvement-A Prospective, Open-Label Pilot Trial
    Silva, Francisco
    Specks, Ulrich
    Kalra, Sanjay
    Hogan, Marie C.
    Leung, Nelson
    Sethi, Sanjeev
    Fervenza, Fernando C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (03): : 445 - 453
  • [33] Mycophenolate mofetil study
    Baltzan, M
    Shoker, A
    Baltzan, R
    TRANSPLANTATION, 1997, 63 (01) : 173 - 174
  • [34] Immunoadsorption patients with multiple sclerosis:: an open-label pilot study
    Moldenhauer, A
    Haas, J
    Wäscher, C
    Derfuss, T
    Hoffmann, KT
    Kiesewetter, H
    Salama, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 523 - 530
  • [35] Open-label study results of conivaptan in patients with severe hyponatremia
    Wagoner, Lynne E.
    Rosansky, Steven
    Verbalis, Joseph G.
    McNutt, Bruce
    Yan, Bo
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A18 - A18
  • [36] Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study
    Bonnekoh, Hanna
    Frischbutter, Stefan
    Roll, Stephanie
    Maurer, Marcus
    Krause, Karoline
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06): : 2486 - +
  • [37] Mycophenolate mofetil - an underestimated MS rescue treatment?
    Marques, I.
    Batista, S.
    Sargento-Freitas, J.
    Macario, C.
    Matias, F.
    Sousa, L.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 440 - 440
  • [38] A Randomized, Open-Label, Phase III Trial Comparing Efficacy and Safety of Intravenous Cyclophosphamide, Mycophenolate Mofetil, or Tacrolimus as Induction Therapy in Lupus Nephritis
    Amudalapalli, Alekhya
    Shukla, Ashlesha
    Maddineni, Abhichandra
    Nagar, Sandeep
    Gadde, Sudhish
    Harish, B., V
    Sahoo, Rashmi Ranjan
    Patro, Pradeepta Sekhar
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1384 - 1387
  • [39] A Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Tacrolimus and Corticosteroids in Combination With or Without Mycophenolate Mofetil in Liver Transplantation Recipients Infected With Hepatitis B Virus
    Park, Jeong-Ik
    Song, Gi-Won
    Ryu, Je Ho
    Choi, Sang-Tae
    Choi, Nam-Gyu
    Jung, Bo-Hyun
    Chu, Chong Woo
    Kim, Keon-Kuk
    Jung, Dong-Hwan
    Ha, Tae-Yong
    Moon, Deok-Bog
    Yang, Kwangho
    Shin, Min -Ho
    Chung, Yong-Kyu
    Hwang, Shin
    Yoon, Young -In
    Lee, Sung-Gyu
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (02) : 387 - 395
  • [40] An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
    Snijders, Romee J. A. L. M.
    Stoelinga, Anna E. C.
    Gevers, Tom J. G.
    Pape, Simon
    Biewenga, Maaike
    Tushuizen, Maarten E.
    Verdonk, Robert C.
    de Jonge, Hendrik J. M.
    Vrolijk, Jan Maarten
    Bakker, Sjoerd F.
    Vanwolleghem, Thomas
    de Boer, Ynto S.
    Pronk, Martine A. M. C. Baven
    Beuers, Ulrich
    van der Meer, Adriaan J.
    van Gerven, Nicole M. F.
    Sijtsma, Marijn G. M.
    van Eijck, Brechje C.
    Ijzendoorn, Manon C. van
    van Herwaarden, Margot
    van den Brand, Floris F.
    Korkmaz, Kerem Sebib
    van den Berg, Aad P.
    Guichelaar, Maureen M. J.
    Levens, Amar D.
    van Hoek, Bart
    Drenth, Joost P. H.
    JOURNAL OF HEPATOLOGY, 2024, 80 (04) : 576 - 585
12345